Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162): effects on cell-mediated immunity
- PMID: 104929
- DOI: 10.1007/BF00910733
Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162): effects on cell-mediated immunity
Abstract
The effects of gold sodium thiomalate (GST) and auranofin (SK&F D-39162) on cell-mediated immunity were investigated using oxazolone-induced contact sensitivity and delayed hypersensitivity to sheep red blood cells. C57Bl mice were sensitized to oxazolone on day 0 and challenged either 45 or 72 h later. The resulting paw edema was read plethysmographically 24 h after challenge. GST and auranofin both were capable of stimulating oxazollone-induced contact sensitivity which was compromised by using a shortened sensitization period (45 h). Auranofin but not GST stimulated the response to oxazolone in immunosuppressed mice, but neither agent significantly altered the uncompromised response in normal mice. The stimulatory effect of auranofin and GST on cell-mediated immunity was corroborated using SRBC to induce delayed hypersensitivity. Comparison of blood Au levels revealed that gold in the form of auranofin was approximately 4x more effective in stimulating cell-mediated immunity than was gold in the form of GST. These results were suggested to be due to the possible stimulation by gold of T effector as well as T suppressor lymphocytes, thus explaining the condition dependency of the immunoregulation.
Similar articles
-
Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.J Rheumatol Suppl. 1979;5:74-81. J Rheumatol Suppl. 1979. PMID: 114651
-
Biologic actions and pharmacokinetic studies of auranofin.Am J Med. 1983 Dec 30;75(6A):90-108. doi: 10.1016/0002-9343(83)90481-3. Am J Med. 1983. PMID: 6318557 Review.
-
[Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].Rev Rhum Mal Osteoartic. 1985 Apr;52(4):277-82. Rev Rhum Mal Osteoartic. 1985. PMID: 3923604 French. No abstract available.
-
Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.J Rheumatol. 1980 Nov-Dec;7(6):820-4. J Rheumatol. 1980. PMID: 6782245
-
The pharmacological profile of auranofin, an orally active gold compound.Scand J Rheumatol Suppl. 1983;51:16-25. doi: 10.3109/03009748309095339. Scand J Rheumatol Suppl. 1983. PMID: 6426049 Review.
Cited by
-
Action of gold salts in some inflammatory and immunological models.Agents Actions. 1980 Apr;10(1 Pt 2):63-77. doi: 10.1007/BF02024180. Agents Actions. 1980. PMID: 7386310
-
Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.Drugs. 1984 May;27(5):378-424. doi: 10.2165/00003495-198427050-00002. Drugs. 1984. PMID: 6426923 Review.
-
Auranofin-induced suppression of autoimmune antibody production and inflammation in genetically autoimmune-prone mice.Inflammation. 1990 Aug;14(4):463-70. doi: 10.1007/BF00914097. Inflammation. 1990. PMID: 2379957
-
Effect of auranofin on antibody-dependent cellular cytotoxicity (ADCC) mediated by rat peripheral blood polymorphonuclear leukocytes and mononuclear cells.Inflammation. 1980 Sep;4(3):279-88. doi: 10.1007/BF00915029. Inflammation. 1980. PMID: 6776048
-
Recent Advances of Gold Compounds in Anticancer Immunity.Front Chem. 2020 Jun 30;8:543. doi: 10.3389/fchem.2020.00543. eCollection 2020. Front Chem. 2020. PMID: 32695747 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Research Materials